{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T16:46:14Z","timestamp":1767804374970,"version":"3.49.0"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T00:00:00Z","timestamp":1764201600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003339","name":"Consejo Superior de Investigaciones Cientificas","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003339","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Commun Signal"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>C3G (RapGEF1) is a guanine nucleotide exchange factor that activates Rap1, a small GTPase implicated in hematologic malignancies. We previously showed that C3G GEF activity is self-repressed via its AIR (autoinhibitory region). A lymphoma-associated missense mutation (Y554H) disrupts this inhibition, resulting in constitutive activation. This study aims to investigate the consequences of C3G dysregulation in B-cell lymphoma.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Murine C3G mutation Y564H (equivalent to human Y554H) was introduced into the A20 B-cell lymphoma line using CRISPR\/Cas9. Rap1 activation, proliferation, apoptosis, ERK1\/2 phosphorylation, Rac2 activity, adhesion, migration, invasion, tumorigenicity, and transcriptomic changes were assessed through biochemical assays, in vitro functional studies, in vivo mouse models, and RNA-seq analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A20-C3G-Y564H cells exhibited increased Rap1 activation under both basal and stimulated conditions. Hyperactivation of the C3G-Rap1 pathway impaired proliferation, promoted apoptosis, and was associated with reduced ERK1\/2 phosphorylation. Furthermore, Rac2 activity was diminished, correlating with altered adhesion properties. Consistently, cell migration and invasion were enhanced, in correspondence with an increased number of metastatic foci in the liver following tail vein injection into syngeneic BALB\/c mice. Notably, reduced C3G expression further augmented the metastatic potential of A20 cells. RNA-seq analysis revealed widespread transcriptional changes involving Rac2 signaling, adhesion, and metastatic pathways.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>C3G plays a dual role in B-cell lymphoma: it acts as a tumor suppressor by inhibiting growth and promoting apoptosis, but may also facilitate metastasis via enhanced motility. This dual effect likely reflects a functional balance between Rap1 and Rac2 signaling. These findings underscore the complexity of C3G-regulated pathways in B cells and suggest that C3G may serve as a potential novel marker in hematologic malignancies.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12964-025-02551-y","type":"journal-article","created":{"date-parts":[[2025,11,27]],"date-time":"2025-11-27T03:16:24Z","timestamp":1764213384000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["C3G deregulation uncovers a dual role in B-cell lymphoma: tumor suppression and enhanced metastasis via Rap1 and Rac2 signaling"],"prefix":"10.1186","volume":"24","author":[{"given":"Alba","family":"Mor\u00e1n-Vaquero","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00d3scar","family":"Herranz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"D\u00e1vila-Hidalgo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonio","family":"Rodr\u00edguez-Bl\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Fern\u00e1ndez-Infante","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ignacio","family":"Garc\u00eda-Tu\u00f1\u00f3n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Vuelta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Femke","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coert","family":"Margadant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carmen","family":"Guerrero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 M.","family":"de Pereda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,27]]},"reference":[{"issue":"4","key":"2551_CR1","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1042\/BSR20100094","volume":"31","author":"V Radha","year":"2011","unstructured":"Radha V, Mitra A, Dayma K, Sasikumar K. Signalling to actin: role of C3G, a multitasking guanine-nucleotide-exchange factor. Biosci Rep. 2011;31(4):231\u201344.","journal-title":"Biosci Rep"},{"issue":"1","key":"2551_CR2","doi-asserted-by":"publisher","first-page":"90","DOI":"10.20892\/j.issn.2095-3941.2016.0086","volume":"14","author":"YL Zhang","year":"2017","unstructured":"Zhang YL, Wang RC, Cheng K, Ring BZ, Su L. Roles of Rap1 signaling in tumor cell migration and invasion. Cancer Biol Med. 2017;14(1):90\u20139.","journal-title":"Cancer Biol Med"},{"key":"2551_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221810018","author":"S Manzano","year":"2021","unstructured":"Manzano S, Gutierrez-Uzquiza A, Bragado P, Cuesta AM, Guerrero C, Porras A. C3G protein, a new player in glioblastoma. Int J Mol Sci. 2021. https:\/\/doi.org\/10.3390\/ijms221810018.","journal-title":"Int J Mol Sci"},{"key":"2551_CR4","doi-asserted-by":"publisher","first-page":"45060","DOI":"10.18632\/oncotarget.9911","volume":"7","author":"N Priego","year":"2016","unstructured":"Priego N, Arechederra M, Sequera C, Bragado P, V\u00e1zquez-Carballo A, Guti\u00e9rrez-Uzquiza A, et al. C3G knock-down enhances migration and invasion by increasing Rap1-mediated p38\u03b1 activation, while it impairs tumor growth through p38\u03b1-independent mechanisms. Oncotarget. 2016;7:45060\u201378.","journal-title":"Oncotarget"},{"issue":"8","key":"2551_CR5","doi-asserted-by":"publisher","DOI":"10.3390\/cancers12082282","volume":"12","author":"C Sequera","year":"2020","unstructured":"Sequera C, Bragado P, Manzano S, Arechederra M, Richelme S, Gutierrez-Uzquiza A, et al. C3G is upregulated in hepatocarcinoma, contributing to tumor growth and progression and to HGF\/MET pathway activation. Cancers (Basel). 2020;12(8):E2282.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"2551_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/s41419-021-03631-w","volume":"12","author":"S Manzano","year":"2021","unstructured":"Manzano S, Gutierrez-Uzquiza A, Bragado P, Sequera C, Herranz O, Rodrigo-Faus M, et al. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells. Cell Death Dis. 2021;12(4):348.","journal-title":"Cell Death Dis"},{"issue":"3","key":"2551_CR7","doi-asserted-by":"publisher","first-page":"456","DOI":"10.1016\/j.bbamcr.2011.01.004","volume":"1813","author":"K Dayma","year":"2011","unstructured":"Dayma K, Radha V. Cytoskeletal remodeling by C3G to induce neurite-like extensions and inhibit motility in highly invasive breast carcinoma cells. Biochim Biophys Acta. 2011;1813(3):456\u201365.","journal-title":"Biochim Biophys Acta"},{"key":"2551_CR8","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1158\/0008-5472.CAN-06-0981","volume":"67","author":"V De Falco","year":"2007","unstructured":"De Falco V, Castellone MD, De Vita G, Cirafici AM, Hershman JM, Guerrero C, et al. RET\/papillary thyroid carcinoma oncogenic signaling through the Rap1 small GTPase. Cancer Res. 2007;67:381\u201390.","journal-title":"Cancer Res"},{"issue":"1","key":"2551_CR9","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1007\/s10238-025-01689-w","volume":"25","author":"T Liu","year":"2025","unstructured":"Liu T, Zhang D, Ouyang W, Li R, Wang S, Liu W. Identification and functional characterization of hub genes CLTA, EDIL3, HAPLN1, and HIP1 as diagnostic biomarkers and therapeutic targets in thyroid cancer and Hashimoto\u2019s thyroiditis. Clin Exp Med. 2025;25(1):162.","journal-title":"Clin Exp Med"},{"key":"2551_CR10","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1007\/s10038-004-0148-1","volume":"49","author":"T Hirata","year":"2004","unstructured":"Hirata T, Nagai H, Koizumi K, Okino K, Harada A, Onda M, et al. Amplification, up-regulation and over-expression of C3G (CRK SH3 domain-binding guanine nucleotide-releasing factor) in non-small cell lung cancers. J Hum Genet. 2004;49:290\u20135.","journal-title":"J Hum Genet"},{"key":"2551_CR11","first-page":"1575","volume":"38","author":"J Samuelsson","year":"2011","unstructured":"Samuelsson J, Alonso S, Ruiz-Larroya T, Cheung TH, Wong YF, Perucho M. Frequent somatic demethylation of RAPGEF1\/C3G intronic sequences in gastrointestinal and gynecological cancer. Int J Oncol. 2011;38:1575\u20137.","journal-title":"Int J Oncol"},{"issue":"2","key":"2551_CR12","doi-asserted-by":"publisher","first-page":"763","DOI":"10.1136\/ijgc-00009577-200603000-00047","volume":"16","author":"K Okino","year":"2006","unstructured":"Okino K, Nagai H, Nakayama H, Doi D, Yoneyama K, Konishi H, et al. Inactivation of Crk SH3 domain-binding guanine nucleotide-releasing factor (C3G) in cervical squamous cell carcinoma. Int J Gynecol Cancer. 2006;16(2):763\u201371.","journal-title":"Int J Gynecol Cancer"},{"key":"2551_CR13","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1016\/j.molmed.2004.06.004","volume":"10","author":"K Kometani","year":"2004","unstructured":"Kometani K, Ishida D, Hattori M, Minato N. Rap1 and SPA-1 in hematologic malignancy. Trends Mol Med. 2004;10:401\u20138.","journal-title":"Trends Mol Med"},{"issue":"6","key":"2551_CR14","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1016\/j.yexcr.2005.12.007","volume":"312","author":"J Gutierrez-Berzal","year":"2006","unstructured":"Gutierrez-Berzal J, Castellano E, Martin-Encabo S, Gutierrez-Cianca N, Hernandez JM, Santos E, et al. Characterization of p87C3G, a novel, truncated C3G isoform that is overexpressed in chronic myeloid leukemia and interacts with Bcr-Abl. Exp Cell Res. 2006;312(6):938\u201348.","journal-title":"Exp Cell Res"},{"key":"2551_CR15","first-page":"1705","volume":"7","author":"T Sakoda","year":"1992","unstructured":"Sakoda T, Kaibuchi K, Kishi K, Kishida S, Doi K, Hoshino M, et al. smg\/rap1\/Krev-1 p21s inhibit the signal pathway to the c-fos promoter\/enhancer from c-Ki-ras p21 but not from c-raf-1 kinase in NIH3T3 cells. Oncogene. 1992;7:1705\u201311.","journal-title":"Oncogene"},{"issue":"5","key":"2551_CR16","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/sj.onc.1201569","volume":"16","author":"C Guerrero","year":"1998","unstructured":"Guerrero C, Fernandez-Medarde A, Rojas JM, Font de Mora J, Esteban LM, Santos E. Transformation suppressor activity of C3G is independent of its CDC25-homology domain. Oncogene. 1998;16(5):613\u201324.","journal-title":"Oncogene"},{"issue":"28","key":"2551_CR17","doi-asserted-by":"publisher","first-page":"4885","DOI":"10.1038\/sj.onc.1207622","volume":"23","author":"C Guerrero","year":"2004","unstructured":"Guerrero C, Martin-Encabo S, Fernandez-Medarde A, Santos E. C3G-mediated suppression of oncogene-induced focus formation in fibroblasts involves inhibition of ERK activation, cyclin A expression and alterations of anchorage-independent growth. Oncogene. 2004;23(28):4885\u201393.","journal-title":"Oncogene"},{"issue":"18","key":"2551_CR18","doi-asserted-by":"publisher","first-page":"3881","DOI":"10.1016\/j.yexcr.2007.07.036","volume":"313","author":"S Mart\u00edn-Encabo","year":"2007","unstructured":"Mart\u00edn-Encabo S, Santos E, Guerrero C. C3G mediated suppression of malignant transformation involves activation of PP2A phosphatases at the subcortical actin cytoskeleton. Exp Cell Res. 2007;313(18):3881\u201391.","journal-title":"Exp Cell Res"},{"issue":"13","key":"2551_CR19","doi-asserted-by":"publisher","first-page":"3333","DOI":"10.1093\/emboj\/20.13.3333","volume":"20","author":"Y Ohba","year":"2001","unstructured":"Ohba Y, Ikuta K, Ogura A, Matsuda J, Mochizuki N, Nagashima K, et al. Requirement for C3G-dependent Rap1 activation for cell adhesion and embryogenesis. EMBO J. 2001;20(13):3333\u201341.","journal-title":"EMBO J"},{"key":"2551_CR20","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1242\/dev.00217","volume":"130","author":"AK Voss","year":"2003","unstructured":"Voss AK, Gruss P, Thomas T. The guanine nucleotide exchange factor C3G is necessary for the formation of focal adhesions and vascular maturation. Development. 2003;130:355\u201367.","journal-title":"Development"},{"issue":"15","key":"2551_CR21","doi-asserted-by":"publisher","first-page":"5873","DOI":"10.7150\/ijbs.73192","volume":"18","author":"N Palao","year":"2022","unstructured":"Palao N, Sequera C, Cuesta AM, Baquero C, Bragado P, Gutierrez-Uzquiza A, et al. C3G down-regulation enhances pro-migratory and stemness properties of oval cells by promoting an epithelial-mesenchymal-like process. Int J Biol Sci. 2022;18(15):5873\u201384.","journal-title":"Int J Biol Sci"},{"issue":"1","key":"2551_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-018-0311-5","volume":"16","author":"S Ortiz-Rivero","year":"2018","unstructured":"Ortiz-Rivero S, Baquero C, Hernandez-Cano L, Roldan-Etcheverry JJ, Gutierrez-Herrero S, Fernandez-Infante C, et al. C3G, through its GEF activity, induces megakaryocytic differentiation and proplatelet formation. Cell Commun Signal. 2018;16(1):101.","journal-title":"Cell Commun Signal"},{"key":"2551_CR23","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.1026287","volume":"10","author":"L Hern\u00e1ndez-Cano","year":"2022","unstructured":"Hern\u00e1ndez-Cano L, Fern\u00e1ndez-Infante C, Herranz O, Berrocal P, Lozano FS, S\u00e1nchez-Mart\u00edn MA, et al. New functions of C3G in platelet biology: contribution to ischemia-induced angiogenesis, tumor metastasis and TPO clearance. Front Cell Dev Biol. 2022;10:1026287.","journal-title":"Front Cell Dev Biol"},{"issue":"4","key":"2551_CR24","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1007\/s12015-021-10136-8","volume":"17","author":"VV Vishnu","year":"2021","unstructured":"Vishnu VV, Muralikrishna B, Verma A, Nayak SC, Sowpati DT, Radha V, et al. C3G regulates STAT3, ERK, adhesion signaling, and is essential for differentiation of embryonic stem cells. Stem Cell Rev Rep. 2021;17(4):1465\u201377.","journal-title":"Stem Cell Rev Rep"},{"key":"2551_CR25","doi-asserted-by":"publisher","first-page":"8564","DOI":"10.1074\/jbc.271.15.8564","volume":"271","author":"L Smit","year":"1996","unstructured":"Smit L, van der Horst G, Borst J. Sos, Vav, and C3G participate in B cell receptor-induced signaling pathways and differentially associate with Shc-Grb2, Crk, and Crk-L adaptors. J Biol Chem. 1996;271:8564\u20139.","journal-title":"J Biol Chem"},{"issue":"5","key":"2551_CR26","doi-asserted-by":"publisher","first-page":"3373","DOI":"10.4049\/jimmunol.181.5.3373","volume":"181","author":"H Chu","year":"2008","unstructured":"Chu H, Awasthi A, White GC, Chrzanowska-Wodnicka M, Malarkannan S. Rap1b regulates B cell development, homing, and T cell-dependent humoral immunity. J Immunol. 2008;181(5):3373\u201383.","journal-title":"J Immunol"},{"issue":"1","key":"2551_CR27","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.immuni.2007.11.019","volume":"28","author":"KB Lin","year":"2008","unstructured":"Lin KB, Freeman SA, Zabetian S, Brugger H, Weber M, Lei V, et al. The rap GTPases regulate B cell morphology, immune-synapse formation, and signaling by particulate B cell receptor ligands. Immunity. 2008;28(1):75\u201387.","journal-title":"Immunity"},{"issue":"3","key":"2551_CR28","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.4049\/jimmunol.169.3.1365","volume":"169","author":"SJ McLeod","year":"2002","unstructured":"McLeod SJ, Li AH, Lee RL, Burgess AE, Gold MR. The Rap GTPases regulate B cell migration toward the chemokine stromal cell-derived factor-1 (CXCL12): potential role for Rap2 in promoting B cell migration. J Immunol. 2002;169(3):1365\u201371.","journal-title":"J Immunol"},{"issue":"4","key":"2551_CR29","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1038\/onc.2009.345","volume":"29","author":"KB Lin","year":"2010","unstructured":"Lin KB, Tan P, Freeman SA, Lam M, McNagny KM, Gold MR. The Rap GTPases regulate the migration, invasiveness and in vivo dissemination of B-cell lymphomas. Oncogene. 2010;29(4):608\u201315.","journal-title":"Oncogene"},{"key":"2551_CR30","doi-asserted-by":"publisher","first-page":"4021","DOI":"10.1038\/onc.2013.362","volume":"33","author":"DR Cook","year":"2014","unstructured":"Cook DR, Rossman KL, Der CJ. Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease. Oncogene. 2014;33:4021\u201335.","journal-title":"Oncogene"},{"issue":"5","key":"2551_CR31","first-page":"769","volume":"5","author":"NV Shirsat","year":"1990","unstructured":"Shirsat NV, Pignolo RJ, Kreider BL, Rovera G. A member of the Ras gene superfamily is expressed specifically in T, B and myeloid hemopoietic cells. Oncogene. 1990;5(5):769\u201372.","journal-title":"Oncogene"},{"issue":"20","key":"2551_CR32","doi-asserted-by":"publisher","first-page":"5445","DOI":"10.1158\/0008-5472.CAN-17-1456","volume":"77","author":"MG Kazanietz","year":"2017","unstructured":"Kazanietz MG, Caloca MJ. The Rac GTPase in cancer: from old concepts to new paradigms. Cancer Res. 2017;77(20):5445\u201351.","journal-title":"Cancer Res"},{"issue":"6","key":"2551_CR33","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1111\/j.1365-2443.2008.01187.x","volume":"13","author":"M Takahashi","year":"2008","unstructured":"Takahashi M, Rikitake Y, Nagamatsu Y, Hara T, Ikeda W, Hirata K, et al. Sequential activation of Rap1 and Rac1 small G proteins by PDGF locally at leading edges of NIH3T3 cells. Genes Cells. 2008;13(6):549\u201369.","journal-title":"Genes Cells"},{"issue":"3","key":"2551_CR34","doi-asserted-by":"publisher","first-page":"E405","DOI":"10.1152\/ajpendo.90874.2008","volume":"296","author":"JA Williams","year":"2009","unstructured":"Williams JA, Chen X, Sabbatini ME. Small G proteins as key regulators of pancreatic digestive enzyme secretion. Am J Physiol Endocrinol Metab. 2009;296(3):E405\u201314.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2551_CR35","doi-asserted-by":"publisher","first-page":"434","DOI":"10.1161\/ATVBAHA.111.239194","volume":"32","author":"L Stefanini","year":"2012","unstructured":"Stefanini L, Boulaftali Y, Ouellette TD, Holinstat M, D\u00e9sir\u00e9 L, Leblond B, et al. Rap1-Rac1 circuits potentiate platelet activation. Arterioscler Thromb Vasc Biol. 2012;32:434\u201341.","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"2551_CR36","doi-asserted-by":"publisher","DOI":"10.1007\/s00018-023-05109-8","volume":"81","author":"C Fern\u00e1ndez-Infante","year":"2024","unstructured":"Fern\u00e1ndez-Infante C, Hern\u00e1ndez-Cano L, Herranz O, Berrocal P, Sicilia-Navarro C, Gonz\u00e1lez-Porras JR, et al. Platelet C3G: a key player in vesicle exocytosis, spreading and clot retraction. Cell Mol Life Sci. 2024;81(1):84.","journal-title":"Cell Mol Life Sci"},{"issue":"1","key":"2551_CR37","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.immuni.2007.12.003","volume":"28","author":"E Arana","year":"2008","unstructured":"Arana E, Vehlow A, Harwood NE, Vigorito E, Henderson R, Turner M, et al. Activation of the small GTPase Rac2 via the B cell receptor regulates B cell adhesion and immunological-synapse formation. Immunity. 2008;28(1):88\u201399.","journal-title":"Immunity"},{"issue":"647","key":"2551_CR38","doi-asserted-by":"publisher","DOI":"10.1126\/scisignal.abb7075","volume":"13","author":"A Carabias","year":"2020","unstructured":"Carabias A, Gomez-Hernandez M, de Cima S, Rodriguez-Blazquez A, Moran-Vaquero A, Gonzalez-Saenz P, et al. Mechanisms of autoregulation of C3G, activator of the GTPase Rap1, and its catalytic deregulation in lymphomas. Sci Signal. 2020;13(647):eabb7075.","journal-title":"Sci Signal"},{"issue":"7360","key":"2551_CR39","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1038\/nature10351","volume":"476","author":"RD Morin","year":"2011","unstructured":"Morin RD, Mendez-Lago M, Mungall AJ, Goya R, Mungall KL, Corbett RD, et al. Frequent mutation of histone-modifying genes in non-Hodgkin lymphoma. Nature. 2011;476(7360):298\u2013303.","journal-title":"Nature"},{"issue":"9","key":"2551_CR40","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.1182\/blood-2012-09-457283","volume":"121","author":"MR Green","year":"2013","unstructured":"Green MR, Gentles AJ, Nair RV, Irish JM, Kihira S, Liu CL, et al. Hierarchy in somatic mutations arising during genomic evolution and progression of follicular lymphoma. Blood. 2013;121(9):1604\u201311.","journal-title":"Blood"},{"issue":"7","key":"2551_CR41","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1038\/nmeth.2019","volume":"9","author":"J Schindelin","year":"2012","unstructured":"Schindelin J, Arganda-Carreras I, Frise E, Kaynig V, Longair M, Pietzsch T, et al. Fiji: an open-source platform for biological-image analysis. Nat Methods. 2012;9(7):676\u201382.","journal-title":"Nat Methods"},{"issue":"3","key":"2551_CR42","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1016\/j.acthis.2018.02.005","volume":"120","author":"JC Stockert","year":"2018","unstructured":"Stockert JC, Horobin RW, Colombo LL, Blazquez-Castro A. Tetrazolium salts and formazan products in cell biology: viability assessment, fluorescence imaging, and labeling perspectives. Acta Histochem. 2018;120(3):159\u201367.","journal-title":"Acta Histochem"},{"issue":"4","key":"2551_CR43","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta delta C(T)) method. Methods. 2001;25(4):402\u20138.","journal-title":"Methods"},{"issue":"7","key":"2551_CR44","first-page":"923","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao Y, Smyth GK, Shi W. Featurecounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinf (Oxford England). 2014;30(7):923\u201330.","journal-title":"Bioinf (Oxford England)"},{"issue":"12","key":"2551_CR45","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","volume":"15","author":"MI Love","year":"2014","unstructured":"Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15(12):550.","journal-title":"Genome Biol"},{"issue":"5","key":"2551_CR46","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, Wang LG, Han Y, He QY. Clusterprofiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"1","key":"2551_CR47","doi-asserted-by":"publisher","first-page":"e1837581","DOI":"10.1080\/23723556.2020.1837581","volume":"8","author":"A Carabias","year":"2021","unstructured":"Carabias A, Guerrero C, de Pereda JM. C3G self-regulatory mechanism revealed: implications for hematopoietic malignancies. Mol Cell Oncol. 2021;8(1):e1837581.","journal-title":"Mol Cell Oncol"},{"issue":"7","key":"2551_CR48","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1016\/j.cellsig.2009.03.015","volume":"21","author":"V Maia","year":"2009","unstructured":"Maia V, Sanz M, Gutierrez-Berzal J, de Luis A, Gutierrez-Uzquiza A, Porras A, et al. C3G Silencing enhances STI-571-induced apoptosis in CML cells through p38 MAPK activation, but it antagonizes STI-571 inhibitory effect on survival. Cell Signal. 2009;21(7):1229\u201335.","journal-title":"Cell Signal"},{"issue":"1","key":"2551_CR49","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1186\/1478-811X-11-9","volume":"11","author":"V Maia","year":"2013","unstructured":"Maia V, Ortiz-Rivero S, Sanz M, Gutierrez-Berzal J, Alvarez-Fern\u00e1ndez I, Gutierrez-Herrero S, et al. C3G forms complexes with Bcr-Abl and p38alpha MAPK at the focal adhesions in chronic myeloid leukemia cells: implication in the regulation of leukemic cell adhesion. Cell Commun Signal. 2013;11(1):9.","journal-title":"Cell Commun Signal"},{"key":"2551_CR50","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/S0092-8674(00)81683-9","volume":"100","author":"D Hanahan","year":"2000","unstructured":"Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57\u201370.","journal-title":"Cell"},{"key":"2551_CR51","doi-asserted-by":"publisher","first-page":"52188","DOI":"10.1074\/jbc.M310656200","volume":"278","author":"R Shivakrupa","year":"2003","unstructured":"Shivakrupa R, Radha V, Sudhakar C, Swarup G. Physical and functional interaction between Hck tyrosine kinase and guanine nucleotide exchange factor C3G results in apoptosis, which is independent of C3G catalytic domain. J Biol Chem. 2003;278:52188\u201394.","journal-title":"J Biol Chem"},{"issue":"3","key":"2551_CR52","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1111\/1440-1681.13027","volume":"46","author":"D Yang","year":"2019","unstructured":"Yang D, Zhang L, Zhang Z, Hu S, Fu Y, Laukkanen JA, et al. Silencing of C3G increases cardiomyocyte survival inhibition and apoptosis via regulation of p-ERK1\/2 and Bax. Clin Exp Pharmacol Physiol. 2019;46(3):237\u201345.","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"3","key":"2551_CR53","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.cellsig.2009.11.008","volume":"22","author":"A Guti\u00e9rrez-Uzquiza","year":"2010","unstructured":"Guti\u00e9rrez-Uzquiza A, Arechederra M, Molina I, Ba\u00f1os R, Maia V, Benito M, et al. C3G down-regulates p38 MAPK activity in response to stress by Rap-1 independent mechanisms: involvement in cell death. Cell Signal. 2010;22(3):533\u201342.","journal-title":"Cell Signal"},{"issue":"10","key":"2551_CR54","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1038\/s41580-020-0255-7","volume":"21","author":"H Lavoie","year":"2020","unstructured":"Lavoie H, Gagnon J, Therrien M. ERK signalling: a master regulator of cell behaviour, life and fate. Nat Rev Mol Cell Biol. 2020;21(10):607\u201332.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"11","key":"2551_CR55","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1038\/nrm1498","volume":"5","author":"C Wellbrock","year":"2004","unstructured":"Wellbrock C, Karasarides M, Marais R. The RAF proteins take centre stage. Nat Rev Mol Cell Biol. 2004;5(11):875\u201385.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6","key":"2551_CR56","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1158\/1078-0432.CCR-16-0021","volume":"23","author":"R Brant","year":"2017","unstructured":"Brant R, Sharpe A, Liptrot T, Dry JR, Harrington EA, Barrett JC, et al. Clinically viable gene expression assays with potential for predicting benefit from MEK inhibitors. Clin Cancer Res. 2017;23(6):1471\u201380.","journal-title":"Clin Cancer Res"},{"issue":"Pt 19","key":"2551_CR57","doi-asserted-by":"publisher","first-page":"3901","DOI":"10.1242\/jcs.03098","volume":"119","author":"JD Humphries","year":"2006","unstructured":"Humphries JD, Byron A, Humphries MJ. Integrin ligands at a glance. J Cell Sci. 2006;119(Pt 19):3901\u20133.","journal-title":"J Cell Sci"},{"key":"2551_CR58","doi-asserted-by":"publisher","first-page":"565458","DOI":"10.3389\/fimmu.2020.565458","volume":"11","author":"Z Nagy-Balo","year":"2020","unstructured":"Nagy-Balo Z, Kiss R, Menge A, Bodor C, Bajtay Z, Erdei A. Activated human memory B lymphocytes use CR4 (CD11c\/CD18) for adhesion, migration, and proliferation. Front Immunol. 2020;11:565458.","journal-title":"Front Immunol"},{"key":"2551_CR59","doi-asserted-by":"publisher","first-page":"908622","DOI":"10.3389\/fcell.2022.908622","volume":"10","author":"H Sun","year":"2022","unstructured":"Sun H, Lagarrigue F, Ginsberg MH. The connection between Rap1 and Talin1 in the activation of integrins in blood cells. Front Cell Dev Biol. 2022;10:908622.","journal-title":"Front Cell Dev Biol"},{"issue":"9","key":"2551_CR60","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nri2606","volume":"9","author":"VL Tybulewicz","year":"2009","unstructured":"Tybulewicz VL, Henderson RB. Rho family GTPases and their regulators in lymphocytes. Nat Rev Immunol. 2009;9(9):630\u201344.","journal-title":"Nat Rev Immunol"},{"issue":"2","key":"2551_CR61","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1083\/jcb.201612069","volume":"217","author":"CD Lawson","year":"2018","unstructured":"Lawson CD, Ridley AJ. Rho GTPase signaling complexes in cell migration and invasion. J Cell Biol. 2018;217(2):447\u201357.","journal-title":"J Cell Biol"},{"issue":"11","key":"2551_CR62","doi-asserted-by":"publisher","first-page":"1627","DOI":"10.1080\/10428190500221454x","volume":"46","author":"MJ Passineau","year":"2005","unstructured":"Passineau MJ, Siegal GP, Everts M, Pereboev A, Jhala D, Wang M, et al. The natural history of a novel, systemic, disseminated model of syngeneic mouse B-cell lymphoma. Leuk Lymphoma. 2005;46(11):1627\u201338.","journal-title":"Leuk Lymphoma"},{"issue":"8","key":"2551_CR63","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1016\/j.bbamcr.2012.05.021","volume":"1823","author":"S Guti\u00e9rrez-Herrero","year":"2012","unstructured":"Guti\u00e9rrez-Herrero S, Maia V, Guti\u00e9rrez-Berzal J, Calzada N, Sanz M, Gonz\u00e1lez-Manch\u00f3n C, et al. C3G transgenic mouse models with specific expression in platelets reveal a new role for C3G in platelet clotting through its GEF activity. Biochimica et Biophysica Acta (BBA). 2012;1823(8):1366\u201377.","journal-title":"Biochimica et Biophysica Acta (BBA)"},{"issue":"67","key":"2551_CR64","doi-asserted-by":"publisher","first-page":"110994","DOI":"10.18632\/oncotarget.22339","volume":"8","author":"V Mart\u00edn-Granado","year":"2017","unstructured":"Mart\u00edn-Granado V, Ortiz-Rivero S, Carmona R, Guti\u00e9rrez-Herrero S, Barrera M, San-Segundo L, et al. C3G promotes a selective release of angiogenic factors from activated mouse platelets to regulate angiogenesis and tumor metastasis. Oncotarget. 2017;8(67):110994\u20131011.","journal-title":"Oncotarget"},{"key":"2551_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-020-0119-9","volume":"5","author":"S Guti\u00e9rrez-Herrero","year":"2020","unstructured":"Guti\u00e9rrez-Herrero S, Fernandez-Infante C, Hernandez-Cano L, Ortiz-Rivero S, Guijas C, Martin-Granado V, et al. C3G contributes to platelet activation and aggregation by regulating major signaling pathways. Signal Transduct Target Ther. 2020;5:29.","journal-title":"Signal Transduct Target Ther"},{"issue":"1","key":"2551_CR66","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-025-01687-1","volume":"18","author":"O Herranz","year":"2025","unstructured":"Herranz O, Berrocal P, Sicilia-Navarro C, Fernandez-Infante C, Hernandez-Cano L, Porras A, et al. C3G promotes bone marrow adipocyte expansion and hematopoietic regeneration after myeloablation by enhancing megakaryocyte niche function. J Hematol Oncol. 2025;18(1):38.","journal-title":"J Hematol Oncol"},{"issue":"8","key":"2551_CR67","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1038\/onc.2011.291","volume":"31","author":"N Kawamata","year":"2012","unstructured":"Kawamata N, Pennella MA, Woo JL, Berk AJ, Koeffler HP. Dominant-negative mechanism of leukemogenic PAX5 fusions. Oncogene. 2012;31(8):966\u201377.","journal-title":"Oncogene"},{"key":"2551_CR68","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/0092-8674(89)90985-9","volume":"56","author":"H Kitayama","year":"1989","unstructured":"Kitayama H, Sugimoto Y, Matsuzaki T, Ikawa Y, Noda M. A ras-related gene with transformation suppressor activity. Cell. 1989;56:77\u201384.","journal-title":"Cell"},{"issue":"18","key":"2551_CR69","doi-asserted-by":"publisher","first-page":"11702","DOI":"10.1074\/jbc.272.18.11702","volume":"272","author":"CD Hu","year":"1997","unstructured":"Hu CD, Kariya K, Kotani G, Shirouzu M, Yokoyama S, Kataoka T. Coassociation of Rap1A and Ha-Ras with Raf-1\u00a0N-terminal region interferes with ras-dependent activation of Raf-1. J Biol Chem. 1997;272(18):11702\u20135.","journal-title":"J Biol Chem"},{"key":"2551_CR70","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1038\/35073073","volume":"2","author":"JL Bos","year":"2001","unstructured":"Bos JL, de Rooij J, Reedquist KA. Rap1 signalling: adhering to new models. Nat Rev Mol Cell Biol. 2001;2:369\u201377.","journal-title":"Nat Rev Mol Cell Biol"},{"key":"2551_CR71","doi-asserted-by":"publisher","first-page":"2952","DOI":"10.1182\/blood-2005-03-1062","volume":"106","author":"PJ Stork","year":"2005","unstructured":"Stork PJ, Dillon TJ. Multiple roles of Rap1 in hematopoietic cells: complementary versus antagonistic functions. Blood. 2005;106:2952\u201361.","journal-title":"Blood"},{"key":"2551_CR72","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1111\/j.1349-7006.2008.01011.x","volume":"100","author":"N Minato","year":"2009","unstructured":"Minato N, Hattori M. Spa-1 (Sipa1) and Rap signaling in leukemia and cancer metastasis. Cancer Sci. 2009;100:17\u201323.","journal-title":"Cancer Sci"},{"issue":"5","key":"2551_CR73","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1182\/bloodadvances.2017013599","volume":"2","author":"P Xiao","year":"2018","unstructured":"Xiao P, Dolinska M, Sandhow L, Kondo M, Johansson AS, Bouderlique T, et al. Sipa1 deficiency-induced bone marrow niche alterations lead to the initiation of myeloproliferative neoplasm. Blood Adv. 2018;2(5):534\u201348.","journal-title":"Blood Adv"},{"key":"2551_CR74","doi-asserted-by":"publisher","first-page":"2878","DOI":"10.1182\/blood-2007-07-103119","volume":"111","author":"SF Wang","year":"2008","unstructured":"Wang SF, Aoki M, Nakashima Y, Shinozuka Y, Tanaka H, Taniwaki M, et al. Development of notch-dependent T-cell leukemia by deregulated Rap1 signaling. Blood. 2008;111:2878\u201386.","journal-title":"Blood"},{"issue":"15","key":"2551_CR75","doi-asserted-by":"publisher","first-page":"2323","DOI":"10.1016\/j.yexcr.2013.04.009","volume":"319","author":"N Minato","year":"2013","unstructured":"Minato N. Rap G protein signal in normal and disordered lymphohematopoiesis. Exp Cell Res. 2013;319(15):2323\u20138.","journal-title":"Exp Cell Res"},{"issue":"8","key":"2551_CR76","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1007\/s00018-016-2136-y","volume":"73","author":"PL Hordijk","year":"2016","unstructured":"Hordijk PL. Recent insights into endothelial control of leukocyte extravasation. Cell Mol Life Sci. 2016;73(8):1591\u2013608.","journal-title":"Cell Mol Life Sci"},{"issue":"5","key":"2551_CR77","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.3892\/ijo.2016.3400","volume":"48","author":"X Zhang","year":"2016","unstructured":"Zhang X, Huang S, Guo J, Zhou L, You L, Zhang T, et al. Insights into the distinct roles of MMP-11 in tumor biology and future therapeutics (Review). Int J Oncol. 2016;48(5):1783\u201393.","journal-title":"Int J Oncol"},{"key":"2551_CR78","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/bs.pmbts.2017.02.005","volume":"147","author":"N Cui","year":"2017","unstructured":"Cui N, Hu M, Khalil RA. Biochemical and biological attributes of matrix metalloproteinases. Prog Mol Biol Transl Sci. 2017;147:1\u201373.","journal-title":"Prog Mol Biol Transl Sci"},{"key":"2551_CR79","doi-asserted-by":"publisher","first-page":"44490","DOI":"10.1074\/jbc.M405144200","volume":"279","author":"AM Valles","year":"2004","unstructured":"Valles AM, Beuvin M, Boyer B. Activation of Rac1 by paxillin-Crk-DOCK180 signaling complex is antagonized by Rap1 in migrating NBT-II cells. J Biol Chem. 2004;279:44490\u20136.","journal-title":"J Biol Chem"},{"issue":"8","key":"2551_CR80","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/s41375-022-01632-y","volume":"36","author":"AE Meyer","year":"2022","unstructured":"Meyer AE, Stelloh C, Pulakanti K, Burns R, Fisher JB, Heimbruch KE, et al. Combinatorial genetics reveals the Dock1-Rac2 axis as a potential target for the treatment of NPM1;Cohesin mutated AML. Leukemia. 2022;36(8):2032\u201341.","journal-title":"Leukemia"},{"key":"2551_CR81","doi-asserted-by":"publisher","DOI":"10.1083\/jcb.202012114","author":"AH Le","year":"2021","unstructured":"Le AH, Yelland T, Paul NR, Fort L, Nikolaou S, Ismail S, et al. CYRI-A limits invasive migration through macropinosome formation and integrin uptake regulation. J Cell Biol. 2021. https:\/\/doi.org\/10.1083\/jcb.202012114.","journal-title":"J Cell Biol"},{"issue":"1","key":"2551_CR82","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01042-2","volume":"21","author":"A Rodriguez-Blazquez","year":"2023","unstructured":"Rodriguez-Blazquez A, Carabias A, Moran-Vaquero A, de Cima S, Luque-Ortega JR, Alfonso C, et al. Crk proteins activate the Rap1 guanine nucleotide exchange factor C3G by segregated adaptor-dependent and -independent mechanisms. Cell Commun Signal. 2023;21(1):30.","journal-title":"Cell Commun Signal"}],"container-title":["Cell Communication and Signaling"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12964-025-02551-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12964-025-02551-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T15:05:30Z","timestamp":1767798330000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12964-025-02551-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,27]]},"references-count":82,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2551"],"URL":"https:\/\/doi.org\/10.1186\/s12964-025-02551-y","relation":{},"ISSN":["1478-811X"],"issn-type":[{"value":"1478-811X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,27]]},"assertion":[{"value":"18 June 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All in vivo experiments were carried out in strict accordance with the guidelines described in the EU Directive 2010\/63\/EU for animal experimentation, including the \u201cthree R\u2019s\u201d rule, and every effort was made to minimize suffering. The protocols were approved by the Committee on the Ethics of Animal Experimentation of the University of Salamanca and the Department of Agriculture, Livestock, and Rural Development, Regional Government of Castilla y Le\u00f3n, Spain (project reference: 1097). The animals were monitored daily after the injection of tumor cells to detect any potential alterations in their well-being. No alterations in animal behavior, including mobility, activity, or weight loss, were observed in any of the cases.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"11"}}